Investors

SciFluor Life Sciences launched in February 2011 with a $5 million funding commitment from Allied Minds. Allied Minds is a private investment firm that deploys capital to form, fund, manage and build companies based on market-creating technologies developed at renowned U.S. universities and federal research institutions. More information about the Boston-based company can be found at www.alliedminds.com

Invesco Asset Management

www.invesco.com

Woodford Patient Capital Trust

www.woodfordfunds.com

SciFluor News

SciFluor Announces Positive Top-Line Results of Phase 1/2 Study of SF0166 Eye Drops to Treat Wet Age-Related Macular Degeneration
read more >

SciFluor Announces 6 New Patent Issuances Covering the Use of SF0166 Topical Ophthalmic Solution in Retinal Diseases
read more >

SciFluor Announces Positive Results of Phase 1/2 Study of SF0166 Topical Ophthalmic Solution in Diabetic Macular Edema Patients
read more >